Epilepsy carries a hidden psychological burden, including interictal dysphoric disorder, anticipatory anxiety, and depression, that affects roughly 1 in 3 people with the condition yet routinely goes unrecognized between seizures, but epilepsy-adapted cognitive behavioral therapy, Acceptance and Commitment Therapy, and other evidence-based approaches deliver proven relief for the fear, hypervigilance, and emotional weight that living with seizures produces.
The dread, irritability, and fear you feel between seizures is not simply part of having epilepsy. It has a name: interictal dysphoric disorder. It is one of the most consistently missed diagnoses in neurology and mental health care, and naming it is where real help can finally begin.
Interictal dysphoric disorder: the clinical name for the fear between seizures nobody sees
If you live with epilepsy and feel waves of dread, irritability, or low mood that seem to arrive and leave on their own schedule, you are not imagining it. There is a name for what you are experiencing: interictal dysphoric disorder, or IDD. It is a psychiatric condition specific to epilepsy, and it is one of the most routinely missed diagnoses in neurology and mental health care alike.
The word interictal simply means “between seizures.” The ictal period is the seizure itself. The postictal period is the recovery window right after. The interictal period is everything in between, and that is precisely where IDD lives. Rather than occurring during or immediately after a seizure, IDD symptoms concentrate in the stretches of time when a person with epilepsy might otherwise expect to feel relatively stable. That timing is part of why it goes unrecognized for so long.
What IDD actually looks like
Researchers have identified eight core symptoms that define IDD: depressive mood, anergia (a deep, physical lack of energy), pain, insomnia, anxiety, irritability, brief periods of euphoric mood, and fear. What makes IDD distinct is not just the list of symptoms but the pattern. These symptoms tend to cluster together, shift in intensity, and then partially or fully lift, only to return. That cycling quality sets IDD apart from both depression and generalized anxiety disorder.
In major depressive disorder, low mood is persistent and relatively uniform over weeks or months. In IDD, depressive episodes are episodic and often mixed with irritability or brief mood elevation, making the overall picture look “pleomorphic,” meaning many-shaped. Standard depression screening tools are built around persistent, uniform low mood, so IDD frequently slips through undetected. The anxiety symptoms in IDD are also distinct from the diffuse, free-floating worry of generalized anxiety disorder. They are tightly linked to the unpredictability of seizures: fear of the next one, fear of when it will happen, fear of losing control in public.
According to research on interictal dysphoric disorder in epilepsy, IDD does not conform cleanly to standard DSM classifications, which is a core reason it is so often missed in routine psychiatric screening. Its neurobiological basis is tied to the same brain networks disrupted by seizure activity, making it an epilepsy-specific phenomenon rather than a coincidental comorbidity. Prevalence estimates vary, but studies suggest IDD affects a meaningful proportion of people with epilepsy, with some figures ranging from roughly 20% to over 60% depending on the population and screening method used.
A symptom checklist you can bring to your care team
If several of the following feel familiar, it is worth raising IDD specifically with your neurologist or therapist:
- Waves of low or depressed mood that come and go without an obvious cause
- Unusual irritability or short-temperedness between seizures
- Profound physical fatigue that feels heavier than ordinary tiredness
- Unexplained pain, particularly headaches or body aches
- Difficulty sleeping or disrupted sleep patterns
- Anxiety or a sense of dread tied to seizure unpredictability
- Brief periods of elevated or unusually good mood that feel out of place
- Persistent fear of when the next seizure will happen
Bringing this list to an appointment and using the term “interictal dysphoric disorder” by name matters. Because IDD does not fit neatly into DSM categories, many clinicians will not screen for it unless prompted. Naming it is the first step toward getting care that actually fits what you are experiencing.
The mental health burden of epilepsy: understanding the full picture
Epilepsy is rarely just a seizure disorder. Psychiatric comorbidities affect approximately 1 in 3 people with epilepsy, a rate 2 to 5 times higher than in the general population. That figure is striking on its own, but what it represents in daily life is even more significant: millions of people managing not just unpredictable seizures, but anxiety, depression, and other mental health conditions that often go unaddressed.
Depression is the most common psychiatric condition among people with epilepsy, and its relationship with seizure disorders runs deeper than cause and effect. Research shows a bidirectional relationship between depression and epilepsy risk: epilepsy raises the likelihood of developing depression, and a pre-existing history of depression independently raises the risk of developing epilepsy. Shared neurotransmitter systems, specifically serotonin, GABA, glutamate, and norepinephrine, along with overlapping brain regions like the temporal lobe, amygdala, and hippocampus, create a biological foundation for why these conditions so frequently co-occur. The connection is neurological, not simply a reaction to living with a difficult diagnosis.
Despite how common psychiatric comorbidity is, mental health has long been sidelined in epilepsy care. Clinical appointments tend to center on seizure frequency, medication adjustments, and neurological monitoring. Mood and anxiety symptoms, when they surface, are often treated as secondary concerns. Patients themselves contribute to this gap: many assume that feeling anxious or low is just part of having epilepsy, rather than a distinct condition that deserves its own attention.
This matters enormously for quality of life. Research consistently shows that psychiatric comorbidity, not seizure frequency, is the strongest predictor of overall well-being in people with epilepsy. Someone experiencing fewer seizures but living with untreated depression often reports a lower quality of life than someone with more frequent seizures and better mental health support. Seizure control is essential, but it is only part of the picture.
Anxiety and epilepsy: living on permanent alert
Depression gets most of the attention when people discuss epilepsy and mental health, but anxiety runs a close second. Anxiety disorders affect between 20 and 30% of people with epilepsy, making them one of the most common psychiatric comorbidities of the condition. Subclinical seizure-related anxiety, the kind that does not meet a formal diagnostic threshold but still shapes every hour of every day, goes largely unmeasured in clinical settings.
To understand what anxiety actually looks like in epilepsy, it helps to separate three distinct layers. The first is generalized anxiety disorder as a standalone clinical diagnosis, which can exist independently or be amplified by the epilepsy itself. The second is ictal anxiety, where the anxiety is the seizure, a symptom generated by abnormal electrical activity, particularly common in temporal lobe epilepsy. The third, and arguably the most pervasive, is interictal anticipatory anxiety: the fear of the next seizure that lives in the spaces between seizures, coloring everything.
The cognitive overhead nobody accounts for
Anticipatory anxiety creates a kind of constant background processing that does not pause. You wake up and, before checking your phone or thinking about breakfast, you are already running a body scan. Does today feel like a seizure day? Is there a heaviness, a strange smell, a flicker at the edge of your vision that might be an aura? This morning assessment is a near-universal behavior among people with epilepsy, and yet it almost never comes up in a neurology appointment.
The mental mapping continues throughout the day. Before entering a room, you clock the hard surfaces, the distance to a door, whether anyone nearby looks capable of helping. Before a shower, you consider whether to sit on the floor of the tub. Before a social event, you rehearse what you would want someone to do if a seizure happened in front of them. Before sleep, you calculate whether you have had enough rest, because sleep deprivation can lower your seizure threshold.
This is what is sometimes called the invisible labor of epilepsy. Bathroom door protocols, the grief of a suspended or revoked driver’s license, the contingency plans for public spaces: none of this shows up on an EEG or a medication log, but it accumulates over months and years into a significant cognitive and emotional weight.
How hypervigilance depletes you even on good days
The sustained state of alertness that anticipatory anxiety produces mirrors the neuropsychological profile of post-traumatic stress disorder, where the nervous system remains on high alert long after the acute threat has passed. In epilepsy, the threat never fully passes, which means the hypervigilance never fully lifts either.
This produces measurable consequences even on completely seizure-free days. Allostatic load, the cumulative wear on the body from chronic stress, builds steadily. Fatigue sets in not because of seizure activity but because of the energy cost of constant vigilance. Executive function, the mental capacity that governs planning, decision-making, and focus, becomes depleted in ways that can look like cognitive side effects of medication but are partly driven by the anxiety itself.
The anxiety and sleep disruption caused by seizure fear can themselves lower seizure threshold, making seizures more likely. More seizures deepen the fear. Deeper fear disrupts sleep further. The loop closes on itself, and breaking it requires addressing both the neurological and the psychological dimensions at once.
How anti-seizure medications affect mood and mental health
When a neurologist prescribes an anti-seizure medication, the goal is seizure control. These medications do not work in isolation, though. They alter the same neurotransmitter systems, including GABA, glutamate, serotonin, and dopamine, that regulate mood, motivation, and emotional stability. According to research on serotonergic pathways linking anti-seizure medications and mood regulation, the psychiatric implications of any given medication are pharmacologically predictable, not random. If you develop depression or irritability after a medication change, it is not a personal failing or a sign that your epilepsy is worsening. It may be a direct effect of the drug itself.
Medications that commonly worsen mood
Levetiracetam (Keppra) is one of the most widely prescribed anti-seizure medications, and it carries a well-documented risk of irritability, aggression, and sudden behavioral changes. Patients often call it “Keppra rage,” a term that captures how out-of-character the emotional shifts can feel. This is not the same as the irritability that comes from epilepsy itself, and it is worth tracking carefully so your care team can make that distinction.
Topiramate is sometimes called “Dopamax” by patients because of how reliably it slows thinking and makes word-finding difficult. Beyond cognitive effects, it carries a real risk of depression and FDA warnings regarding suicidality. If you are prescribed topiramate and notice your mood dropping or your thinking becoming foggy, those symptoms deserve immediate attention.
Phenobarbital has a strong association with depression and cognitive dulling. For anyone with a pre-existing mood disorder, this medication requires especially close psychiatric monitoring. Perampanel carries warnings for irritability and aggression that become more pronounced at higher doses.
Medications with mood-stabilizing properties
Not every anti-seizure medication destabilizes mood. Lamotrigine is one of the few with documented mood-stabilizing properties, and it is actually used as a treatment for bipolar disorder. For people with epilepsy who also experience mood symptoms, lamotrigine may improve psychiatric wellbeing rather than worsen it. Valproate also has mood-stabilizing effects, though its metabolic side effects and risks during pregnancy carry their own psychological weight, particularly for women navigating family planning decisions.